0      0

Fall Meeting 2013

Diabetes Update

Sep 20, 2013 8:30am ‐ Sep 20, 2013 12:00pm

Standard: $40.00
Members: $0.00


New medications, new rules, new monitoring. At a time when the incidence and prevalence rates of diabetes are continuing to skyrocket, knowing how to provide the best care possible for individuals diagnosed with diabetes is important. This session focuses on that care. Whether you are an APN or an RN, you will find the information provided in this session invaluable.

Contact hours available until 9/22/2015.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Conflict of Interest Disclosure:
Betsy Dokken - Advisory Board, Takeda Pharmaceuticals; Advisory Board, Sanofi; Consultant/Speaker’s Bureau, Takeda

Conference Committee Disclosures:
Dawn Koonkongsatian – Employee, Fresenius Medical Care
Kristin Larson – Employee, NxStage Medical
Denise Murcek – Employee, Fresenius Medical Care
Beth St. John - Employee, Fresenius Medical Care
Lucy Todd – Employee, Baxter Healthcare
Kyra Trappett – Employee, DaVita

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.


  • Identify effective lifestyle strategies to prevent type 2 diabetes (T2DM) in high-risk patients.
  • Promote glycemic control in patients with diabetes.
  • Adopt health care practices that may prevent complications and disabilities associated with diabetes.
  • Review and apply current algorithms for the pharmacologic treatment of diabetes.


You must be logged in and own this session in order to post comments.